- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Pharma committee to be constituted by the centre
An inter ministerial coordination committee under the supervision of the central govt will soon be formed to closely monitor the growth of the 2 Lakh crore Indian pharma sector.Department of Pharmaceuticals Secretary V K Subburaj, will supervise the committee while representatives from 10 different department or bodies will form the core member team .So, now the pharmaceutical companies...
An inter ministerial coordination committee under the supervision of the central govt will soon be formed to closely monitor the growth of the 2 Lakh crore Indian pharma sector.
Department of Pharmaceuticals Secretary V K Subburaj, will supervise the committee while representatives from 10 different department or bodies will form the core member team .
So, now the pharmaceutical companies will have access to one central body to listen to their concerning issues, and getting them resolved through a common channel of communication.
"It has been decided to constitute an Inter-Ministerial Coordination Committee as recommended by the 'Task Force on Enabling Private Sector to lead the Growth of Pharmaceutical Industry'," Department of Pharmaceuticals said in a note.
The committee may also invite other government agencies/officials or representatives of industry and their associations to the meeting for more effective resolution of the pending issues.
Other members of the committee include representatives from various departments like department of industrial policy and promotion, commerce, science and technology, bio-technology, environment, health and family welfare and revenue.
Besides these, the committee will also have representatives from drug price regulator NPPA (National Pharmaceutical Pricing Authority) and Central Pollution Control Board.
The Drug Controller General of India will also be a member of the committee.
Earlier, the task force in its report had suggested that the Department of Pharmaceuticals may come up with seed capital and facilitate funding with other financial institutions for the medium and small scale players in the pharmaceuticals industry.
Department of Pharmaceuticals Secretary V K Subburaj, will supervise the committee while representatives from 10 different department or bodies will form the core member team .
So, now the pharmaceutical companies will have access to one central body to listen to their concerning issues, and getting them resolved through a common channel of communication.
"It has been decided to constitute an Inter-Ministerial Coordination Committee as recommended by the 'Task Force on Enabling Private Sector to lead the Growth of Pharmaceutical Industry'," Department of Pharmaceuticals said in a note.
The committee may also invite other government agencies/officials or representatives of industry and their associations to the meeting for more effective resolution of the pending issues.
Other members of the committee include representatives from various departments like department of industrial policy and promotion, commerce, science and technology, bio-technology, environment, health and family welfare and revenue.
Besides these, the committee will also have representatives from drug price regulator NPPA (National Pharmaceutical Pricing Authority) and Central Pollution Control Board.
The Drug Controller General of India will also be a member of the committee.
Earlier, the task force in its report had suggested that the Department of Pharmaceuticals may come up with seed capital and facilitate funding with other financial institutions for the medium and small scale players in the pharmaceuticals industry.
Next Story